Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001178913-24-003417
Filing Date
2024-10-31
Accepted
2024-10-31 17:24:24
Documents
118

Document Format Files

Seq Description Document Type Size
1 S-1 zk2432189.htm   iXBRL S-1 4753502
2 EXHIBIT 23.1 exhibit_23-1.htm EX-23.1 3099
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM exhibit_23-2.htm EX-23.2 3362
4 EXHIBIT 107 exhibit_107.htm EX-FILING FEES 57496
5 GRAPHIC image0.jpg GRAPHIC 394107
6 GRAPHIC image1.jpg GRAPHIC 719720
7 GRAPHIC image2.jpg GRAPHIC 696772
8 GRAPHIC image3.jpg GRAPHIC 315577
9 GRAPHIC image4.jpg GRAPHIC 566080
10 GRAPHIC image5.jpg GRAPHIC 622547
11 GRAPHIC image6.jpg GRAPHIC 1028065
12 GRAPHIC image7.jpg GRAPHIC 187927
  Complete submission text file 0001178913-24-003417.txt   27388365

Data Files

Seq Description Document Type Size
13 XBRL SCHEMA FILE slxn-20240630.xsd EX-101.SCH 134382
14 XBRL CALCULATION FILE slxn-20240630_cal.xml EX-101.CAL 35599
15 XBRL DEFINITION FILE slxn-20240630_def.xml EX-101.DEF 544289
16 XBRL LABEL FILE slxn-20240630_lab.xml EX-101.LAB 1127762
17 XBRL PRESENTATION FILE slxn-20240630_pre.xml EX-101.PRE 657043
121 EXTRACTED XBRL INSTANCE DOCUMENT zk2432189_htm.xml XML 2143887
Mailing Address 12 ABBA HILLEL ROAD RAMAT GAN L3 5250606
Business Address 12 ABBA HILLEL ROAD RAMAT GAN L3 5250606 972-8-6286005
Silexion Therapeutics Corp (Filer) CIK: 0002022416 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-282932 | Film No.: 241416263
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)